Artboard 33Artboard 16Artboard 18Artboard 13Artboard 42Artboard 21Artboard 4Artboard 5Artboard 45Artboard 22Artboard 7Artboard 42Artboard 23Artboard 17?Artboard 28Artboard 43Artboard 49Artboard 47Artboard 15Artboard 32Artboard 6Artboard 22Artboard 5Artboard 25Artboard 1Artboard 42Artboard 11Artboard 41Artboard 11Artboard 23Artboard 10Artboard 4Artboard 9Artboard 6Artboard 8Artboard 7Artboard 3Artboard 12Artboard 25Artboard 34Artboard 43Artboard 44Artboard 16Artboard 24Artboard 13Artboard 5Artboard 24Artboard 31Artboard 1Artboard 12Artboard 27Artboard 30Artboard 36Artboard 44Artboard 9Artboard 17Artboard 6Artboard 27Artboard 30Artboard 29Artboard 26Artboard 2Artboard 20Artboard 35Artboard 15Artboard 14Artboard 50Artboard 26Artboard 14Artboard 40Artboard 21Artboard 10Artboard 37Artboard 46Artboard 33Artboard 8
e-book

1992-Planning for Chemicals, Pharmaceuticals and Biotechnology (Cód: 9609275)

Eurofi Plc

ELSEVIER S&T

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 212,60

em até 7x de R$ 30,37 sem juros

Total:

Em até 1x sem juros de


Crédito:
Boleto:
Cartão Saraiva:

Total:

Em até 7x sem juros de


1992-Planning for Chemicals, Pharmaceuticals and Biotechnology

R$212,60

Descrição

1992-Planning for Chemicals, Pharmaceuticals and Biotechnology provides a summary of the relevant legislation, research programs, and proposals for the establishment of a single European market for the chemical, pharmaceutical, and biotechnology industries. The development of the European Community'apos;s (EC) policy and the implications of its implementation for the EC and third country markets are discussed. The views from a number of major organizations that operate in the chemical, pharmaceutical, and biotechnology markets are considered to provide an insight into some of the factors influencing strategic planning for 1992.
This book consists of 10 chapters and opens with an overview of the EC'apos;s goal of establishing a single market for the European Union by 1992, followed by a discussion on the implications of this single market for industry, commerce, and individuals. The following chapters focus on the Single European Act; corporate issues such as mergers and acquisitions; standards of good practice in the chemical, pharmaceutical, and biotechnology sectors; and implications of a single European market for these industries. The final chapter is devoted to the views of organizations in the chemical, pharmaceutical, and biotechnology sectors such as the European Chemical Industry Federation (CEFIC), Bayer AG, and COLIPA (European Cosmetic Industry Federation) in terms of the opportunities, problems, and challenges of the single European market.
This monograph will be a useful resource for corporate managers, especially those in the IT sector, as well as policymakers and industry regulators.

Características

Peso 0.00 Kg
Produto sob encomenda Sim
Marca ELSEVIER S&T
Número de Páginas 412 (aproximado)
Idioma 337
Acabamento e-book
Territorialidade Internacional
Formato Livro Digital Pdf
Gratuito Não
Proteção Drm Sim
Tamanho do Arquivo 45998
Início da Venda 22/10/2013
Código do Formato Pdf
Cód. Barras 9781483161754
Ano da Publicação 113
AutorEurofi Plc